Emilia Licarete

About Emilia Licarete

Emilia Licarete, With an exceptional h-index of 25 and a recent h-index of 22 (since 2020), a distinguished researcher at Universitatea Babes-Bolyai, specializes in the field of Immunology, Molecular Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo

Silver (I) complexes with diorganochalcogen ligands of type (2-MeC6H4CH2) 2E (E= S, Se). Synthesis, structure and antiproliferative activity

The use of functionalized liposomes and extracellular vesicles as drug delivery systems with high cancer-targeting efficacy.

Overcoming doxorubicin resistance in B16. F10 melanoma cells by targeting Hypoxia-Inducible Factor-1 alpha.

3D tumor spheroids as a model to unriddle the complexity of tumor microenvironment chemoresistance.

Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer

Active tumor-targeting nano-formulations containing simvastatin and doxorubicin inhibit melanoma growth and angiogenesis

Emilia Licarete Information

University

Position

Lecturer and Centre for Systems Biology Biodiversity and Bioresources "3B"

Citations(all)

1580

Citations(since 2020)

1211

Cited By

852

hIndex(all)

25

hIndex(since 2020)

22

i10Index(all)

43

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Emilia Licarete Skills & Research Interests

Immunology

Molecular Biology

Top articles of Emilia Licarete

Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo

Journal of Liposome Research

2024/2/20

Silver (I) complexes with diorganochalcogen ligands of type (2-MeC6H4CH2) 2E (E= S, Se). Synthesis, structure and antiproliferative activity

Inorganica Chimica Acta

2024/2/15

The use of functionalized liposomes and extracellular vesicles as drug delivery systems with high cancer-targeting efficacy.

Studia Universitatis Babes-Bolyai, Historia Artium

2023/7/1

Overcoming doxorubicin resistance in B16. F10 melanoma cells by targeting Hypoxia-Inducible Factor-1 alpha.

Studia Universitatis Babes-Bolyai, Historia Artium

2023/7/1

3D tumor spheroids as a model to unriddle the complexity of tumor microenvironment chemoresistance.

Studia Universitatis Babes-Bolyai, Historia Artium

2023/7/1

Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo

Cancer Biology & Therapy

2022/12/31

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer

Molecular Medicine

2022/12

Active tumor-targeting nano-formulations containing simvastatin and doxorubicin inhibit melanoma growth and angiogenesis

Frontiers in Pharmacology

2022/4/5

SERS liquid biopsy profiling of serum for the diagnosis of kidney cancer

Biomedicines

2022/1/22

On the coordination behaviour of diorganoselenium ligands based on amino and azole functionalities: silver (i) complexes with relevance for biological applications

New Journal of Chemistry

2022

Folate-targeted Pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer

Colloids and Surfaces B: Biointerfaces

2021/7/1

Novel combined therapy based on IL-13-PEG-LCL-SIM and PEG-EV-DOX to reduce murine melanoma aggresiveness in vivo.

Studia Universitatis Babes-Bolyai, Biologia

2021/6/1

The impact of composites with silicate-based glasses and gold nanoparticles on skin wound regeneration

Molecules

2021/1

Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin

Journal of Liposome Research

2021/1/2

Synthesis, structural characterization and in vitro antiproliferative effects of novel organotin (iv) compounds with nicotinate and isonicotinate moieties on carcinoma cells

2011

Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions

Journal of cellular and molecular medicine

2021/12

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression

Scientific reports

2021/11/11

Composites based on silicate bioactive glasses and silver iodide microcrystals for tissue engineering applications

Journal of Non-Crystalline Solids

2020/11/1

Emilia Licarete
Emilia Licarete

H-Index: 16

Lucian Baia
Lucian Baia

H-Index: 23

Overcoming intrinsic doxorubicin resistance in melanoma by anti-angiogenic and anti-metastatic effects of liposomal prednisolone phosphate on tumor microenvironment

International journal of molecular sciences

2020/4/23

CHARACTERIZATION AND ANALYSIS OF RGO THIN FILMS WITH APPLICATION ON COLON-26 TUMOR CARCINOMA-BEARING MOUSE CELLS.

International Journal of Medical Dentistry

2020/4/1

Emilia Licarete
Emilia Licarete

H-Index: 16

Simion Astilean
Simion Astilean

H-Index: 32

See List of Professors in Emilia Licarete University(Universitatea Babes-Bolyai)